Absence of an independent association between serum uric acid and left ventricular mass in Caucasian hypertensive women and men

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 23, Issue 8, 2013, Pages 715-722

  Mule G ^a   Nardi, E ^a   Costanzo, M ^a   Mogavero, M ^a   Guarino, L ^a   Viola, T ^a   Vario, M G ^a   Cacciatore, V ^a   Andronico, G ^a   Cerasola, G ^a   Cottone, S ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

Cardiovascular risk; Essential hypertension; Left ventricular hypertrophy; Left ventricular mass; Serum uric acid

Indexed keywords

CREATININE; URIC ACID;

ADULT; ARTICLE; BLOOD; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; BODY MASS; CARDIOVASCULAR RISK; CAUCASIAN; CROSS-SECTIONAL STUDY; ECHOCARDIOGRAPHY; ESSENTIAL HYPERTENSION; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART VENTRICLE; HUMAN; HYPERTENSION; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; URIC ACID BLOOD LEVEL;

CARDIOVASCULAR RISK; ESSENTIAL HYPERTENSION; LEFT VENTRICULAR HYPERTROPHY; LEFT VENTRICULAR MASS; SERUM URIC ACID;

ADULT; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; BODY MASS INDEX; CREATININE; CROSS-SECTIONAL STUDIES; ECHOCARDIOGRAPHY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEART VENTRICLES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; URIC ACID;

EID: 84880035920     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2012.01.007     Document Type: Article

References (30)

1. Feig D., Kang D.H., Johnson R. Uric acid and cardiovascular risk. N Engl J Med 2008, 359:1811-1821.
2. Strazzullo P., Puig J.G. Uric acid and oxidative stress: relative impact on cardiovascular risk?. Nutr Metab Cardiovasc Dis 2007, 17:409-414. 10.1016/j.numecd.2007.02.011.
3. Lin C.S., Hung Y.J., Chen G.Y., Tzeng T.F., Lee D.Y., Chen C.Y., et al. A multicenter study of the association of serum uric acid, serum creatinine, and diuretic use in hypertensive patients. Int J Cardiol 2011, 148:325-330. 10.1016/j.ijcard.2009.11.024.
4. Onat A., Uyarel H., Hergenc G., Karabulut A., Albayrak S., Sari I., et al. Serum uric acid is a determinant of metabolic syndrome in a population-based study. Am J Hypertens 2006, 19:1055-1062.
5. Bonora E., Capaldo B., Cavallo Perin P., Del Prato S., De Mattia G., Frittitta L., et al. Hyperinsulinemia and insulin resistance are independently associated with plasma lipids, uric acid and blood pressure in non-diabetic subjects. the GISIR database. Nutr Metab Cardiovasc Dis 2008, 18:624-631. 10.1016/j.numecd.2007.05.002.
6. Viazzi F., Leoncini G., Ratto E., Falqui V., Parodi A., Conti N., et al. Mild hyperuricaemia and subclinical renal damage in untreated primary hypertension. Am J Hypertens 2007, 20:1276-1282.
7. Cerasola G., Mulè G., Nardi E., Cusimano P., Palermo A., Arsena R., et al. Clinical correlates of renal dysfunction in hypertensive patients without cardiovascular complications: the REDHY study. J Hum Hypertens 2010, 24:44-50.
8. Iwashima Y., Horio T., Kamide K., Rakugi H., Ogihara T., Kawano Y. Uric acid, left ventricular mass index, and risk of cardiovascular disease in essential hypertension. Hypertension 2006, 47:195-202.
9. Vakili B.A., Okin P.M., Devereux R.B. Prognostic implications of left ventricular hypertrophy. Am Heart J 2001, 141:334-341. 10.1067/mhj.2001.113218.
10. Corry D.B., Eslami P., Yamamoto K., Nyby M.D., Makino H., Tuck M.L. Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin system. J Hypertens 2008, 26:269-275.
11. Yu M.A., Sanchez-Lozada L.G., Johnson R.J., Kang D.H. Oxidative stress with an activation of the renin-angiotensin system in human vascular endothelial cells as a novel mechanism of uric acid-induced endothelial dysfunction. J Hypertens 2010, 28:1234-1242.
12. Cheng T.H., Lin J.W., Chao H.H., Chen Y.L., Chen C.H., Chan P., et al. Uric acid activates extracellular signal-regulated kinases and thereafter endothelin-1 expression in rat cardiac fibroblasts. Int J Cardiol 2010, 139:42-49. 10.1016/j.ijcard.2008.09.004.
13. Mitsuhashi H., Yatsuya H., Matsushita K., Zhang H., Otsuka R., Muramatsu T., et al. Uric acid and left ventricular hypertrophy in Japanese men. Circ J 2009, 73:667-672.
14. Matsumura K., Ohtsubo T., Oniki H., Fujii K., Iida M. Gender-related association of serum uric acid and left ventricular hypertrophy in hypertension. Circ J 2006, 70:885-888.
15. Kurata A., Shigematsu Y., Higaki J. Sex-related differences in relations of uric acid to left ventricular hypertrophy and remodeling in Japanese hypertensive patients. Hypertens Res 2005, 28:133-139.
16. Viazzi F., Parodi D., Leoncini G., Parodi A., Falqui V., Ratto E., et al. Serum uric acid and target organ damage in primary hypertension. Hypertension 2005, 45:991-996.
17. Xaplanteris P., Vlachopoulos C., Vyssoulis G., Terentes-Printzios D., Alexopoulos N., Lazaros G., et al. Uric acid levels, left ventricular mass and geometry in newly diagnosed, never treated hypertension. J Hum Hypertens 2011, 25:340-342.
18. Campo C., Ruilope L.M., Segura J., Rodicio J.L., Garcia-Robles R., Garcia-Puig J. Hyperuricemia, low urine urate excretion and target organ damage in arterial hypertension. Blood Press 2003, 12:277-283.
19. Tsioufis C., Chatzis D., Vezali E., Dimitriadis K., Antoniadis D., Zervoudaki A., et al. The controversial role of serum uric acid in essential hypertension: relationships with indices of target organ damage. J Hum Hypertens 2005, 19:211-217.
20. Cuspidi C., Valerio C., Sala C., Meani S., Esposito A., Zanchetti A., et al. Lack of association between serum uric acid and organ damage in a never-treated essential hypertensive population at low prevalence of hyperuricemia. Am J Hypertens 2007, 20:678-685.
21. Perticone F., Maio R., Ruberto C., Cassano S., Tripepi G., Perticone M., et al. Kidney function and risk factors for left ventricular hypertrophy in untreated uncomplicated essential hypertension. Am J Kidney Dis 2008, 52:74-84. 10.1053/j.ajkd.2008.02.302.
22. Salvetti M., Muiesan M.L., Paini A., Agabiti Rosei C., Aggiusti C., Stassaldi D., et al. Relationship between serum uric acid and arterial stiffness and cardiac and carotid artery structure in a general population in Northern Italy. J Hypertens 2010, e588-e589.
23. Guidelines for the management of arterial hypertension. J Hypertens 2007, 25:1105-1187. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).
24. Levey A., Stevens L.A., Schmid C.H., Zhang Y.L., Castro A.F., Feldman H.I., et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009, 150:604-612.
25. Alberti K.G., Eckel R.H., Grundy S.M., Zimmet P.Z., Cleeman J.I., Donato K.A., et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009, 120:1640-1645.
26. Sahn D.J., DeMaria A., Kisslo J., Weiman A. The committee on M-mode standardization of the American society of echocardiography. Circulation 1978, 58:1072-1073.
27. Lang R.M., Bierig M., Devereux R.B., Flachskampf F.A., Foster E., Pellikka P.A., et al. Recommendations for chamber quantification. Eur J Echocardiography 2006, 7:79-108.
28. de Simone G., Daniels S.R., Devereux R.B., Meyer R.A., Roman M.J., de Divitiis O., et al. Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and the impact of overweight. J Am Coll Cardiol 1992, 20:1251-1260. 10.1016/0735-1097(92)90385-Z.
29. Liao Y., Cooper R.S., Durazo-Arvizu R., Mensah G.A., Ghali G.K. Prediction of mortality risk by different methods of indexation for left ventricular mass. J Am Coll Cardiol 1997, 29:641-647. 10.1016/S0735-1097(96)00552-9.
30. Kanellis J., Watanabe S., Li J.H., Kang D.H., Li P., Nakagawa T., et al. Uric acid stimulates monocyte chemoattractant protein-1 production in vascular muscle cells via mitogen-activated protein kinase and cycloxygenase-2. Hypertension 2003, 41:1287-1293.